A recent article suggests that use of nonsteroidal anti-inflammatory drugs (NSAIDs) might help to reduce the risk of developing Alzheimer’s Disease, if prescription were to be commenced years before clinical signs were to develop.
An NHS Choices Behind the Headlines critical appraisal examines this paper, and offers a sense of perspective by discussing the remaining uncertainties.
Claims ibuprofen ‘will wipe out Alzheimer’s’ are misleading. London: NHS Choices; Behind the Headlines, March 28th 2018.
This relates to:
McGeer, PL. Guo, JP. And] Lee, M. [et al] (2018). Alzheimer’s Disease can be spared by nonsteroidal anti-inflammatory drugs. Journal of Alzheimer’s Disease. March 13th 2018; 62(3): 1219-1222.